Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of$ 0.18. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 11.11%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.17 per share when it actually produced a loss of $0.15, delivering a surprise of 11.76%.Over the last four quarters, the compa ...